$CDT News

Last published 6d ago

6d agoCDTTrading halt: CDT Equity Inc. Common Stock (CDT), Volatility trading pauseNasdaq Trading HaltsHalted 2026-11-06 09:38:01.743 ET, resumption quote 2026-11-06 09:38:01 ET, resumption trade none.
6d agoCDTTrading halt: CDT Equity Inc. Common Stock (CDT), News pendingNasdaq Trading HaltsHalted 2026-11-05 19:50:00.000 ET, resumption quote none, resumption trade none.
1w agoCDTCDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded PeptidesGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 30, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today welcomed a significant development in the U.S. regulatory
2w agoCDTCDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of LaunchGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into an evaluation agreement
4w agoCDTCDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory AssetGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding
1mo agoCDTCDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and VitiligoGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into a partnership with QIMA
2mo agoCDTCDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental HealthGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding the
2mo agoCDTCDT Provides Capital Update and Confirms No Nasdaq DeficienciesGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced that, following the recent issuance of shares and
2mo agoCDTCDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of GrowthGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 01, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the appointment of James Bligh, co-founder of
2mo agoCDTCDT Validates Enhanced Solid-Form Properties Within Its IP PortfolioGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that new solid forms and alternative crystal
2mo agoCDTCDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide MarketGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into a SAFE note with Pep'd
3mo agoCDTCDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property ExpansionGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced that it has entered into a strategic transaction to
3mo agoCDTCDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to SugarcaneGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the
3mo agoCDTCDT Equity Inc. Announces Reverse Stock SplitGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, July 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-for-10
4mo agoCDTCDT Highlights Sarborg's Application of Quantum Computing to Solid-Form DevelopmentGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the
4mo agoCDTCDT Notes Strategic Investment into Sarborg and Expansion into Quantum ComputingGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding its recent fundraise from
4mo agoCDTCDT Equity Announces Debt Update and New Loan FacilityGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has re-structured its debt, agreeing to pay off all
5mo agoCDTCDT Equity Inc. Announces Receipt of Nasdaq Deficiency LetterGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that the Company received a written notice ("Notice") from the Nasdaq
5mo agoCDTCDT Announces Canadian Patent for AZD5904 in Male InfertilityGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that the patent covering the use of AZD5904 in male infertility has
6mo agoCDTCDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis MarketGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the filing of a new
6mo agoCDTCDT Advances AZD5904 into Global Patent Phase and Initiates Partnering DiscussionsGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that AZD5904, a potent inhibitor of human Myeloperoxidase, originally
7mo agoCDTCDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven DiscoveryGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today provides a strategic update outlining its positioning as a multi-pathway
7mo agoCDTCDT Notes Sarborg Publication of PRISM Framework Expanding AIGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, April 07, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the publication of its
7mo agoCDTCDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent FilingsGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced the filing of two new patent applications that further expand the
7mo agoCDTCDT Equity Inc. Announces Reverse Stock SplitGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") announces that its board of directors has approved a 1-for-25 reverse stock split of
7mo agoCDTCDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing StrategyGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 23, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announces that it has completed initial signature mapping of its asset
8mo agoCDTCDT Notes Sarborg Expansion into Rare Disease Signature IntelligenceGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 12, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the expansion of its
8mo agoCDTCDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature AgentGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today notes the announcement issued by Sarborg Limited ("Sarborg") regarding the
8mo agoCDTCDT Positions for Transformational GrowthGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, March 04, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") advances multiple initiatives designed to enhance shareholder value and expand its
8mo agoCDTCDT Equity Notes Sarborg Expansion into Bacteria and AgrochemicalsGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 24, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement issued this morning by Sarborg Limited regarding the
8mo agoCDTCDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset StrategyGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into a strategic transaction to acquire a 20%
10mo agoCDTCDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing StrategyGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 02, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has engaged NJS Foresight Bio-Advisory, LLC to identify,
1y agoCDTCDT Equity Increases Bitcoin HoldingGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced the acquisition of 9.25648743 Bitcoin ("BTC") for an aggregate
1y agoCDTCDT Equity Inc. Announces Reverse Stock SplitGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-for-8 reverse stock split of
1y agoCDTCDT Executes Cryptocurrency Treasury Reserve StrategyGlobeNewswireNAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the strategic acquisition of 8.65252366 Bitcoin ("BTC") for an
1y agoCDTCDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve StrategyGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced that, following its strategic review of the
1y agoCDTCDT Equity Identifies New Biological Target Validating AI-Driven Repurposing StrategyGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announces that it has successfully identified a new biological target and novel
1y agoCDTConduit to Change Name to CDT Equity Inc.GlobeNewswireName change to CDT Equity Inc. reflects evolution of strategy and focus on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation, strategic partnerships and out-licensing
1y agoCDTConduit Engages Consultant to Explore Cryptocurrency Reserve StrategyGlobeNewswireIndependent advisor appointed to assess feasibility and strategic benefit of a partial cryptocurrency-based treasury reserveInitiative aims to diversify capital positioning while retaining focus on IP-driven
1y agoCDTConduit Pharmaceuticals Files New Patents Following AI-Driven Combination DiscoveriesGlobeNewswireIncludes Conduit's first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658Patents derived from AI-led analysis conducted in partnership with Sarborg Limited
1y agoCDTConduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal HealthGlobeNewswireCollaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal health
1y agoCDTConduit Pharmaceuticals Inc. Listing on Nasdaq Capital MarketGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 22, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit" or the "Company"), a dynamic, multi-asset clinical stage, life science company
1y agoCDTConduit Pharmaceuticals Inc. Regains Nasdaq ComplianceGlobeNewswireConduit regains compliance with Bid Price and Equity RequirementsCDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) --
1y agoCDTConduit Pharmaceuticals Inc. Announces Reverse Stock SplitGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit" or the "Company"), a dynamic, multi-asset clinical stage, life science company
1y agoCDTConduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune DiseasesGlobeNewswireConduit secures a composition of matter patent from the Korean Intellectual Property Office for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune disorders, positioning the Company for clinical
1y agoCDTConduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline AssetGlobeNewswireNew patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit's pipeline, unlocking up to 20 years of new IP runway and enabling enhanced formulation strategies to
1y agoCDTConduit Pharmaceuticals Announces Leadership ChangesGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced
1y agoCDTConduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension ProspectsGlobeNewswireConduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug
1y agoCDTConduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase ProgramGlobeNewswireNAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (NASDAQ:CDT) ("Conduit" or the "Company") today announced that its Board of Directors has authorized a
1y agoCDTConduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline OptimizationGlobeNewswireConduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize development pathways.